Observational studyJournal of the American Society of Nephrology : JASN2017

Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous Nephropathy.

Jan A J G van den Brand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.